Description
HIV protease substrate ARVLAEA is a peptide binding epitope of the capsid CA-p2 cleavage site.
| Product Unit Size | Cost | Quantity | Stock |
|---|
HIV protease substrate ARVLAEA is a peptide binding epitope of the capsid CA-p2 cleavage site.
| Purity | ≥98% |
|---|---|
| Formula | C33H59N11O10 |
| Formula Wt. | 769.90 |
| Solubility | Soluble in water (2 mg/mL), acetonitrile. |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
Prabu-Jeyabalan M, Nalivaika E, Schiffer CA. How does a symmetric dimer recognize an asymmetric substrate? A substrate complex of HIV-1 protease. J Mol Biol. 2000 Sep 1;301(5):1207-20. PMID: 10966816.
Nucleoside (adenosine) analog; DNA chain termin...
TGFbeta receptor inhibitor
Mycotoxin contaminant found in cereal grains.
Fermentation impurity
Imidazoquinoline nucleoside analog; TLR-7/8 ago...
Prenylated flavonoid found in Humulus lupulus.<...
Piperazine; FIASMA, D2 antagonist, hERG K+ chan...
Stable salt form of hyperforin, a compound foun...
FAK inhibitor.
Lincosamide; peptidyl transferase inhibitor, pr...
Modified nucleotide used for labeling DNA; DNA ...
Terpene lactone found in Ginkgo; GSK-3β inhibi...
Smo inhibitor.
mTOR inhibitor.
Peptide, involved in synapse formation and cell...
Coumarin; VKORC1 inhibitor.
pan-RAF inhibitor
Nucleoside (deoxyadenosine) analog; DNA chain t...
Alkaloid found in Catharanthus, precursor in sy...
beta-catenin inhibitor